On February 27, 2025, the Board of Directors filled the vacancy created by Mr. Morgan’s retirement by appointing Rob Buchner as a Class III member of the Board of Directors.
Departed
Charles Morgan
Class III member of the Board of Directors; Lead Independent Director; Chairman of the Nominating and Corporate Governance Committee; member of the Audit Committee
On February 27, 2025, Charles Morgan notified the Company of his retirement, effective immediately, from his position as a Class III member of the Company’s Board of Directors and from his positions as Lead Independent Director, Chairman of the Nominating and Corporate Governance Committee and member of the Audit Committee.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Rob Buchner was appointed as Class III member of the Board of Directors at Inuvo, Inc..
Action
appointed
Role
Class III member of the Board of Directors
Exact text from the filing
On February 27, 2025, the Board of Directors filled the vacancy created by Mr. Morgan’s retirement by appointing Rob Buchner as a Class III member of the Board of Directors.
Charles Morgan retired as Class III member of the Board of Directors; Lead Independent Director; Chairman of the Nominating and Corporate Governance Committee; member of the Audit Committee at Inuvo, Inc..
Action
retired
Role
Class III member of the Board of Directors; Lead Independent Director; Chairman of the Nominating and Corporate Governance Committee; member of the Audit Committee
Exact text from the filing
On February 27, 2025, Charles Morgan notified the Company of his retirement, effective immediately, from his position as a Class III member of the Company’s Board of Directors and from his positions as Lead Independent Director, Chairman of the Nominating and Corporate Governance Committee and member of the Audit Committee.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.